Vident Advisory’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.9M Sell
80,631
-80,201
-50% -$21.3M 0.28% 74
2026
Q1
$17.6M Buy
160,832
+150,991
+1,534% +$21.5M 0.15% 120
2025
Q4
$1.64M Buy
9,841
+2,021
+26% +$338K 0.01% 639
2025
Q3
$1.53M Buy
7,820
+5,090
+186% +$837K 0.01% 655
2025
Q2
$247K Sell
2,730
-734
-21% -$58K ﹤0.01% 1398
2025
Q1
$207K Buy
+3,464
New +$320K ﹤0.01% 1435

Other funds holding ALAB

Vident Advisory's ALAB Position: Q2 2026 in Review

Vident Advisory reduced its Astera Labs (ALAB) stake by 50% in Q2 2026, selling an estimated $21.3M and leaving 80,631 shares worth $38.9M. The position accounts for 0.28% of the portfolio, ranked #74.

Vident Advisory first reported a position in ALAB in Q1 2025 and has held it in 6 quarters since. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Vident Advisory held 80,631 shares of Astera Labs worth $38.9M as of Q2 2026.
  • Vident Advisory sold 80,201 Astera Labs shares in Q2 2026, an estimated $21.3M.
  • Astera Labs made up 0.28% of Vident Advisory's portfolio in Q2 2026, its #74 holding.
  • Vident Advisory first reported a position in Astera Labs in Q1 2025 and has held it in 6 quarters since.
  • 993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.